Viewpoint Wiki - All Viewpoints, No Gatekeepers

The history of global drug prohibition policies reflects evolving social, political, and cultural attitudes toward intoxicants. This article traces the origins and development of anti-drug measures from early localized bans to modern decriminalization movements. For broader context, see War On Drugs (Main Topic); for differing perspectives on policy approaches, visit drug-policy-viewpoint-diversity; and for discussions on public health alternatives, explore harm-reduction-debate.

- scope of article: origins and evolution of global drug prohibition policies - link to war-on-drugs (Main Topic) - link to drug-policy-viewpoint-diversity - link to harm-reduction-debate

The first significant U.S. drug prohibition measure was San Francisco's 1875 anti-opium ordinance, which historians have linked to xenophobic sentiments of the era directed at Chinese immigrants. The federal government later entered the fray with the 1906 Pure Food and Drug Act, which mandated truthful labeling but did not ban substances outright. International coordination began at the 1912 Hague Convention, resulting in the first global treaty on drug control.

Domestic prohibition took firmer shape with the 1914 Harrison Narcotics Tax Act, which imposed taxes on opiates and coca derivatives while effectively criminalizing their medical use. The law set precedents for federal drug enforcement, administered by Harry Anslinger's Federal Bureau of Narcotics (FBN). Anslinger's tenure saw sustained campaigns against marijuana, exemplified by the 1936 propaganda film *Reefer Madness*, which amplified fears of cannabis despite scant evidence.

Anslinger expanded his efforts in the 1930s, culminating in the 1937 Marihuana Tax Act, which imposed prohibitive taxes on marijuana and curtailed its legal use. The narrative around drugs grew increasingly political with President Richard Nixon's 1970 National Commission on Marihuana and Drug Abuse, which examined substance use in the context of broader social unrest.

Nixon's 1971 declaration of a “War on Drugs” explicitly tied prohibition to racial and anti-radical narratives, as later documented in White House tapes and statements by Nixon administration officials. The 1973 creation of the Drug Enforcement Administration (DEA) under President Nixon consolidated enforcement efforts by merging agencies including the Bureau of Narcotics and Dangerous Drugs and the Office of Drug Abuse Law Enforcement. Public campaigns, such as First Lady Nancy Reagan's “Just Say No” initiative, further entrenched punitive drug policies.

The 1980s saw stark disparities in sentencing for crack versus powder cocaine, formalized by the 1986 Anti-Drug Abuse Act's 100:1 ratio for mandatory minimums. This period also marked heightened emphasis on interdiction strategies, despite debates over their effectiveness.

The 21st century brought shifts toward decriminalization, exemplified by Portugal's 2001 model and Oregon's 2020 ballot measure decriminalizing drug possession (Measure 110), which was subsequently reversed by the state legislature in 2024. The Office of National Drug Control Policy (ONDCP) underwent reforms focusing on harm reduction, while President Obama's administration prioritized treatment over incarceration through clemency initiatives for nonviolent drug offenders.

Cannabis policy saw significant changes with Canada's 2018 legalization and state-level reforms in the U.S., guided by federal memoranda like the Cole Memorandum. In 2022, President Biden took steps toward federal marijuana decriminalization, including pardons for simple possession offenses.

Some historians argue that racism was a driving force behind early drug laws, such as those targeting marijuana and crack cocaine racism-driving-force-behind-drug-laws-controversy. The effectiveness of supply-side interdiction strategies remains disputed among policymakers interdiction-effectiveness-controversy. The role of the pharmaceutical industry in the opioid crisis is a subject of legal and academic debate, particularly regarding Purdue Pharma's marketing practices pharmaceutical-industry-opioid-crisis-controversy. Racial disparities in drug enforcement have been documented by organizations like the ACLU racial-disparities-drug-enforcement-controversy.

* War On Drugs * drug-policy-viewpoint-diversity * harm-reduction-debate * Prohibition - History

1. Michelle Alexander, *The New Jim Crow: Mass Incarceration in the Age of Colorblindness* (New York: The New Press, 2010). 2. David Courtwright, *The Age of Addiction: How Bad Habits Became Big Business* (Cambridge, MA: Harvard University Press, 2021). 3. Craig Reinarman, “Crack and Powdered Cocaine: Let's Just Say Don't Snort It,” *Public Policy & Aging Report* 5, no. 4 (1994): 7-11.